DUPIXENT is a prescription medicine used as an add-on maintenance treatment in adults and children 6 years of age and older who have moderate-to-severe eosinophilic or oral steroid dependent asthma that is not controlled with their current asthma medicines. DUPIXENT is not used to treat sudden breathing problems and will not replace an inhaled rescue medicine.
NOT ON DUPIXENT
Asthma patients on DUPIXENT
saw nearly 2x change in
breathing improvement
at 2 weeks compared to placebo*
*In a breathing test, 140 mL with
DUPIXENT vs 80 mL with placebo.
ON DUPIXENT
Patient images are portrayals
DUPIXENT was studied in a clinical trial with 408 children 6 to
11 years old with
persistent
moderate-to-severe asthma.†
†In those with high eosinophil counts ≥300 cells/μL (a type of white blood cell), either a type 2 inflammatory asthma phenotype (≥150 blood eosinophils per mm3 or a fraction of exhaled nitric oxide of ≥20 ppb at baseline) or a blood eosinophil count of ≥300 blood eosinophils per mm3.
‡The annual rate of severe asthma attacks in pediatric patients with a blood eosinophil count of ≥300 blood eosinophils per mm3 was 0.24 with DUPIXENT 200 mg vs 0.67 with placebo.
§Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
The safety results of DUPIXENT observed in children
through Week 52 were similar to the safety profile from studies
in adults and
adolescents with moderate-to-severe asthma, with the addition of parasitic (helminth)
infections.
The most common side effects include:
View the possible side effects of DUPIXENT in patients with moderate-to-severe
eosinophilic or oral corticosteroid–dependent asthma.
Our pediatric patient brochure is filled with helpful information about how DUPIXENT
works, plus fun activity pages for your child.
After talking with our asthma doctor,
we started to feel more comfortable
with the idea of trying something
different. In our opinion, it was the best
decision we have made for Aston.
Christan,
Caregiver of Aston (real patient).
Individual results may vary.
Take charge of the discussion with your child's doctor
around your child's asthma care with this helpful guide.
Sign up to receive exclusive emails and resources, providing information on:
Check out the caregiver support page for helpful
DUPIXENT injection tips, guidance, and support.
In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Some patients in the DUPIXENT groups saw improved lung function in as little as 2 weeks.
Learn how DUPIXENT helped treat patients 12+ years old with their moderate-to-severe asthma.
